Ann Neurol

1. SABATINO JJ JR, Cree BAC, Hauser SL
   New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond.
   Ann Neurol. 2025 Jun 6. doi: 10.1002/ana.27270.
   

   >> Share

   
   

   
   BMC Neurol

2. YALCIN GY, Tulek Z, Kurtuncu M
   Effect of a nurse-led online patient support program on fatigue, sleep and quality of life in patients with multiple sclerosis: a quasi-experimental study.
   BMC Neurol. 2025;25:238.
   

   >> Share

   
   
3. AZIMIRAD M, Hamtaeigashti S, Raeisi H, Looha MA, et al
   Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran.
   BMC Neurol. 2025;25:234.
   

   >> Share

   
   
4. KOUCHAKI E, Bayat S, Asgarian FS
   Sleep disorders in patients with multiple sclerosis.
   BMC Neurol. 2025;25:237.
   

   >> Share

   
   

   
   J Clin Invest

5. POLONIO CM, Quintana FJ
   Therapeutic B cell depletion identifies immunoregulatory networks.
   J Clin Invest. 2025;135:e189442.
   

   >> Share

   
   

   
   J Neurol

6. CHEN H
   A disproportionality analysis of nervous system adverse events associated with disease-modifying therapies in multiple sclerosis: insights from the FDA adverse event reporting system (FAERS).
   J Neurol. 2025;272:445.
   

   >> Share

   
   
7. MALUCCHI S, Bava CI, Valentino P, Martire S, et al
   Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting.
   J Neurol. 2025;272:444.
   

   >> Share

   
   
8. NEYAL N, Krey KJ, Morrison HA, Nathoo N, et al
   From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis.
   J Neurol. 2025;272:434.
   

   >> Share

   
   

   
   J Neurol Neurosurg Psychiatry

9. YAMOUT B, Alroughani R, Mohamed SFA, Al-Mahdawi AM, et al
   Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study.
   J Neurol Neurosurg Psychiatry. 2025 Jun 1:jnnp-2024-335704.
   

   >> Share

   
   

   
   Magn Reson Med

10. BALAJI S, Wiley N, Dvorak A, Padormo F, et al
    Magnetization transfer imaging using non-balanced SSFP at ultra-low field.
    Magn Reson Med. 2025;94:602-614.
    

    >> Share

    
    

    
    Mult Scler

11. MOCCIA M
    Clinical commentary to gender-affirming interventions and prognosis in multiple sclerosis.
    Mult Scler. 2025 Jun 3:13524585251341177. doi: 10.1177/13524585251341177.
    

    >> Share

    
    
12. NEYAL N, Nathoo N, Cathcart-Rake EJ, Kantarci OH, et al
    Gender-affirming interventions and prognosis in multiple sclerosis.
    Mult Scler. 2025 Jun 3:13524585251341174. doi: 10.1177/13524585251341174.
    

    >> Share

    
    
13. NOVAKOVA L, Rosenstein I, Axelsson M, Schoonheim MM, et al
    Plateau of practice effects and noise with repeat SDMT testing and in multiple sclerosis.
    Mult Scler. 2025 May 31:13524585251344794. doi: 10.1177/13524585251344794.
    

    >> Share

    
    

    
    Neurology

14. JIA A, Price TR, Rosner J, Broderick C, et al
    Journal Club: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e213663.
    

    >> Share

    
    
15. GOYNE C, Fair AE, Yilmaz D, Race J, et al
    Epigenetic Aging in Pediatric-Onset Multiple Sclerosis.
    Neurology. 2025;104:e213673.
    

    >> Share

    
    
16. YEH EA
    Accelerated Aging in Children With Multiple Sclerosis: Can We Stop the Clock?
    Neurology. 2025;104:e213840.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share